Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology von Guillot Morales, Mónica, Visa, Laura, Brozos Vázquez, Elena, Feliu Batlle, Jaime, Khosravi Shahi, Parham, Laquente Sáez, Berta, de San Vicente Hernández, Borja López, Macarulla, Teresa, Gironés Sarrió, Regina

Volltext

Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial von Tempero, Margaret A, Pelzer, Uwe, O'Reilly, Eileen M, Winter, Jordan, Oh, Do-Youn, Li, Chung-Pin, Tortora, Giampaolo, Chang, Heung-Moon, Lopez, Charles D, Bekaii-Saab, Tanios, Ko, Andrew H, Santoro, Armando, Park, Joon Oh, Noel, Marcus S, Frassineti, Giovanni Luca, Shan, Yan-Shen, Dean, Andrew, Riess, Hanno, Van Cutsem, Eric, Berlin, Jordan, Philip, Philip, Moore, Malcolm, Goldstein, David, Tabernero, Josep, Li, Mingyu, Ferrara, Stefano, Le Bruchec, Yvan, Zhang, George, Lu, Brian, Biankin, Andrew V, Reni, Michele

Volltext

Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology von Guillot Morales, Mónica, Visa Turmo, Laura, Brozos Vázquez, Elena, Feliu Batlle, Jaime, Khosravi Shahi, Parham, Laquente Sáez, Berta, López de San Vicente Hernández, Borja, Macarulla, Teresa, Gironés i Sarrió, Regina

Volltext

Síndrome de supresión del antiandrógeno: estrategia terapéutica en el cáncer de próstata andrógeno-independiente von Sáez, Berta Laquente, Galcerán, Joan Carles

Volltext

Phase III APACT trial of adjuvant nab- paclitaxel plus gemcitabine ( nab -P + Gem) versus gemcitabine (Gem) alone for patients with resected pancreatic cancer (PC): Outcomes by geo... von Reni, Michele, Riess, Hanno, O'Reilly, Eileen Mary, Park, Joon Oh, Hatoum, Hassan, Saez, Berta Laquente, Salminen, Tapio, Oettle, Helmut, Lopez, Rafael, Dowden, Scot D., Karthaus, Meinolf, Tabernero, Josep, Van Cutsem, Eric, Philip, Philip Agop, Goldstein, David, Berlin, Jordan, Tempero, Margaret A.

Volltext

Metronomic chemotherapy following the maximum tolerated dose as a multitarget antitumor therapy affecting angiogenesis, tumor dissemination, and cancer stem cells von Vives, Marta, Ginestà, Mireia M., Gracova, Kristina, Graupera, Mariona, Casanovas, Oriol, Capella, Gabriel, Serrano, Teresa, Vinyals, Francesc, Saez, Berta Laquente

Volltext

Pimasertib plus gemcitabine in metastatic pancreatic adenocarcinoma: Results of a safety run-in part of a phase II trial von Verslype, Chris, Hammel, Pascal, Hidalgo, Manuel, Macarulla, Teresa, Garcia-Carbonero, Rocio, André, Thierry, Van Den Eynde, Marc, Saez, Berta Laquente, Milella, Michele, Raymond, Eric, Faivre, Thea, Milner, Alvin, Tarabaric, Dolores, Locatelli, Giuseppe, Richter, Oliver von, Laffranchi, Bernard, Van Cutsem, Eric

Volltext

Characterization of HER2/neu and topoisomerase IIα status by FISH in locally advanced breast cancer von Contero, Cristina Corzo, Trias de Bes, Ignacio Tusquets, Galeote, Marta Salido, Corominas Torres, Josep Maria, Saez, Berta Laquente, Ezquerra, Meritxel Bellet, Mayol, Xavier Fabregat, Figueras, Sergio Serrano, Ristol, Francesc Solé

Volltext